Cme Group Inc

1. 1

   Election of Equity Directors

   ManagementBoard: FOR

   Elect 14 Equity directors to serve until the 2027 annual meeting.

2. 2

   Ratification of Ernst & Young LLP as Independent Registered Public Accounting Firm for 2026

   ManagementBoard: FOR

   Ratify the board-appointed Ernst & Young LLP as CME Group’s independent registered public accounting firm for 2026.

   More detail

   The proposal asks shareholders to ratify the audit committee’s selection of Ernst & Young LLP as the company’s independent registered public accounting firm for 2026. Management seeks this advisory ratification as good governance practice though shareholder approval is not required; the audit committee retains the discretion to change auditors regardless of the vote. The filing emphasizes benefits of continuity — EY’s long tenure since 2002 provides deep institutional knowledge of CME Group’s complex global operations, accounting policies and internal controls — and cost advantages from existing efficiencies. The audit committee’s review focused on audit quality, independence, EY’s technical resources and global capabilities, historical performance and PCAOB inspection data. The company discloses audit and non-audit fees and its pre-approval processes designed to protect auditor independence. A “FOR” vote aligns investors with the audit committee’s assessment that EY remains qualified and that continuity supports audit quality; a vote against would signal investor concerns and could trigger the audit committee to reconsider the engagement. Risks to investors include perceived audit tenure concentration, which the proxy addresses via lead partner rotation and committee oversight.

3. 3

   Advisory Vote on the Compensation of Named Executive Officers (Say-on-Pay

   ManagementBoard: FOR

   Non-binding advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.

   More detail

   This non-binding advisory proposal asks shareholders to approve CME Group’s 2025 executive compensation as disclosed in the proxy. Management positions the program as pay-for-performance with at least 50% of NEO target compensation performance-based, using cash-earnings-funded bonuses, performance shares tied to TSR and absolute net income margin, and time-vested restricted stock. The compensation committee engaged an independent consultant, considered shareholder feedback and implemented design changes (e.g., double-trigger change-in-control, vesting cap on TSR awards if absolute TSR negative, addition of an absolute net income margin metric). Management argues that these features align executives with shareholder outcomes while managing risk via caps and clawback policies. A FOR vote supports management’s view that the program is appropriately structured and responsive to shareholder feedback; an AGAINST vote signals investor dissatisfaction and could prompt further changes. The vote is not binding, but the committee will consider the result when shaping future pay policies.

4. 4

   Approval of Amendment to Certificate of Incorporation to Eliminate Class B-1 Director Election Rights

   ManagementBoard: FOR

   Approve amendment to eliminate Class B-1 shareholders' right to elect three directors and provide cash consideration ($6,200 per Class B-1 share) upon surrender.

   More detail

   This management proposal seeks shareholder approval to amend the certificate of incorporation to eliminate the Class B-1 shareholders’ statutory right to elect three directors beginning at the 2027 annual meeting, and to implement conforming bylaw changes. The board argues the Class B-1 process has failed to produce valid elections due to chronically low quorum/voter participation, leaving Class B directors as long-standing 'holdovers' and impeding board refreshment and governance flexibility. Management proposes $6,200 cash per Class B-1 share (625 total shares) as consideration upon surrender of the election rights. The board frames this as modernization to align governance with market practice while preserving member representation through nominations; it points to continued avenues to include market participants on the full slate of Equity directors. The proposal raises key governance tradeoffs: eliminating guaranteed member-elected seats centralizes director selection and can enhance board agility and independence, but also removes a structural safeguard for direct market participant representation. The cash payment likely reflects negotiated valuation of the election rights; tax treatment is noted as generally taxable to recipients. Approval requires both a “for” vote of a majority of outstanding Class B-1 shares and a majority of Class A and Class B shares voting together, and abstentions/broker non-votes count as against. The board recommends FOR, arguing benefits outweigh loss of structural Class B representation; opponents may focus on minority shareholder protections, preserving member influence, and adequacy of the payment.

5. 5

   Approval of Amendment to Certificate of Incorporation to Eliminate Class B-2 Director Election Rights

   ManagementBoard: FOR

   Approve amendment to eliminate Class B-2 shareholders' right to elect two directors and provide cash consideration ($4,100 per Class B-2 share) upon surrender.

   More detail

   This management proposal seeks shareholder approval to amend the certificate of incorporation to eliminate the Class B-2 shareholders’ right to elect two directors beginning at the 2027 annual meeting, with $4,100 cash per Class B-2 share (813 total shares) as consideration. The board's rationale mirrors Item 4: chronic low voting participation has prevented valid Class B elections, creating holdover directors and hampering board refreshment and governance agility. The company argues elimination modernizes governance, aligns with investor expectations, and retains market-participant expertise via nominating processes. The proposal implicates governance and fairness issues: removing guaranteed Class B seats centralizes nomination authority and could enhance board flexibility and independence, but reduces member-elected safeguards. Vote thresholds require both a majority of the Class B-2 shares and a majority of Class A and Class B voting together; abstentions and broker non-votes count as votes against the amendment. The board recommends FOR, while opponents may highlight the loss of structural member influence and question the adequacy of cash consideration.

6. 6

   Approval of Amendment to Certificate of Incorporation to Eliminate Class B-3 Director Election Rights

   ManagementBoard: FOR

   Approve amendment to eliminate Class B-3 shareholders' right to elect one director and provide cash consideration ($2,000 per Class B-3 share) upon surrender.

   More detail

   This management proposal seeks shareholder approval to amend the certificate of incorporation to eliminate the Class B-3 shareholders’ right to elect one director beginning at the 2027 annual meeting, with $2,000 cash per Class B-3 share (1,287 total shares) as consideration. The board's rationale is consistent with Items 4 and 5: the Class B-3 election process has seen low voter participation, leading to holdover directors and constraint on board composition and refreshment. Eliminating the right is presented as a modernization consistent with best practices and investor feedback while offering cash compensation to affected Class B holders. Governance tradeoffs are similar: the company gains flexibility and potentially improved governance, but Class B shareholders lose an institutional mechanism to guarantee direct representation of market participants. The proposal requires a majority vote of the Class B-3 shares and also a majority of Class A and Class B voting together; abstentions and broker non-votes count as against. The board recommends FOR; critics may question member representation and sufficiency of compensation.

7. 7

   Approval of Amendment to Certificate of Incorporation to Remove Inoperative Provisions

   ManagementBoard: FOR

   If Items 4–6 are approved, approve conforming amendments to remove provisions that would be inoperative after eliminating Class B election rights.

   More detail

   This management proposal requests shareholder approval to amend the certificate of incorporation to remove or clarify provisions that would be inoperative if Items 4–6 are approved and filed. It is purely conforming and contingent upon approval of the Class B Election Rights amendments. The board frames the amendment as a technical housekeeping measure to implement the intended corporate governance modernization. The proposal only requires a majority vote of Class A and Class B shareholders voting together and will not be filed or implemented unless all of Items 4–6 pass. The board recommends FOR to ensure legal clarity and consistency following the substantive charter amendments.

8. 8

   Election of Class B-1, Class B-2 and Class B-3 Directors

   ManagementBoard: FOR

   Elect three Class B-1 directors, one Class B-2 director and one Class B-3 director to serve until the 2027 annual meeting.

Upcoming shareholder meetings at Cme Group Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Cme Group Inc 2026 annual meeting?

Cme Group Inc (CME) holds its 2026 annual shareholder meeting on Thursday, May 14, 2026.

What is the record date for the Cme Group Inc 2026 meeting?

The record date for the Cme Group Inc 2026 meeting is Monday, March 16, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Cme Group Inc's 2026 meeting?

The board is presenting 16 director nominees at the Cme Group Inc 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Cme Group Inc 2026 meeting?

Shareholders will vote on 8 proposals at the Cme Group Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.